BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6092192)

  • 1. Antibody to the hepatitis B virus-associated delta-agent in immune serum globulins.
    Ponzetto A; Hoofnagle JH; Seeff LB
    Gastroenterology; 1984 Dec; 87(6):1213-6. PubMed ID: 6092192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study.
    Rosina F; Saracco G; Rizzetto M
    N Engl J Med; 1985 Jun; 312(23):1488-91. PubMed ID: 3990749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
    Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to the hepatitis B surface antigen in immune serum globulin.
    Hoffnagle JH; Gerety RJ; Barker LF
    Transfusion; 1975; 15(5):408-13. PubMed ID: 1198681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of hepatitis B surface antigen in commercially prepared plasma products.
    Hoofnagle JH; Gerety RJ; Thiel J; Barker LF
    J Lab Clin Med; 1976 Jul; 88(1):102-13. PubMed ID: 932529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
    Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
    J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity.
    Farci P; Smedile A; Lavarini C; Piantino P; Crivelli O; Caporaso N; Toti M; Bonino F; Rizzetto M
    Gastroenterology; 1983 Sep; 85(3):669-73. PubMed ID: 6873613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
    Lyra LG
    Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Delta infection in HBsAg carriers].
    Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High titre of antibody to hepatitis B core antigen detected by immune adherence haemagglutination in HBsAg-positive acute hepatitis.
    Ikegami F; Takasu S; Jo K; Miyakawa Y; Tsuda F; Mayumi M
    Hepatogastroenterology; 1982 Aug; 29(4):142-3. PubMed ID: 7129336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic delta hepatitis: a difficult problem for the hepatologist.
    Picciotto A; Celle G
    Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay detection of IgM antibodies to the hepatitis B core antigen in HBsAg liver disease.
    Lavarini C; Crivelli O; Smedile A; Farci P; Marinucci G; Muglia M; Rizzetto M
    Boll Ist Sieroter Milan; 1982; 61(3):210-7. PubMed ID: 6985422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The frequency of HBsAg in plasma donors, and the incidence of anti HBs, anti HBc, anti HBe and anti HAV in HBsAg negative plasma donors in Zagreb (author's transl)].
    Grgicević D; Pistotnik M; Mikulicić V; Marchiotti I
    Lijec Vjesn; 1980 Sep; 102(9):475-7. PubMed ID: 6264240
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis B and the delta agent].
    Jilg W; Roggendorf M; Zoulek G; Schlipköter U; Deinhardt F
    Fortschr Med; 1984 Feb; 102(6):119-21. PubMed ID: 6706267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of antibody to hepatitis B core antigen by means of immune adherence hemagglutination.
    Tsuda F; Takahashi T; Takahashi K; Miyakawa Y; Mayumi M
    J Immunol; 1975 Sep; 115(3):834-8. PubMed ID: 1171142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg].
    Ren F; Li H; Zhao H
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.